Moreover, given that atherosclerosis, the basic pathological change occurring in CVD, is primarily promoted by chronic inflammation induced by hyperlipidemia (Zhao et al., 2021), the role of PCSK9 in inflammation has attracted the attention of many researchers in recent years. Here, PCSK9 is linked to hyperlipidemia.